MetaCap

Lantheus Quarterly Income Statement

NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

100.15+0.03 (+0.03%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Lantheus revenue and earnings

In the quarter ended Jun 30, 2026, Lantheus generated $388.2 million in revenue, up 2.7% from the same quarter a year earlier. Net income was $75.0 million (-4.7% year over year), for a net margin of 19.3% versus a median of 19.6% in the prior 5 quarters. Gross margin was 62.3% (down from 63.8%) and operating margin 25.8%.

Diluted earnings per share came in at $1.11, down from $1.12.

Summary generated from market data by MetaCap's automated system. Methodology

Lantheus income statement (quarterly)

Lantheus quarterly income statement
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31Q3 20232023-09-30
Revenue388.18M377.33M406.79M384.01M378.05M372.76M391.11M378.73M394.09M369.98M354.00M319.95M
Revenue growth (YoY)+2.68%+1.23%+4.01%+1.39%-4.07%+0.75%+10.48%+18.37%+22.50%+23.00%+34.52%+33.71%
Cost of Revenue146.32M146.41M165.91M161.65M137.03M135.06M142.56M136.61M138.32M128.13M124.13M120.00M
Gross Profit241.85M230.92M240.88M222.37M241.01M237.70M248.54M242.13M255.77M241.85M229.87M199.95M
Operating Expenses141.64M149.60M163.69M178.75M153.04M135.63M134.67M108.38M153.04M135.21M92.38M87.59M
Research & Development38.20M39.38M47.48M48.02M45.49M36.31M35.33M24.15M60.60M48.02M16.82M14.45M
Selling, General & Admin103.44M110.22M116.21M130.73M107.56M99.32M101.51M84.23M92.44M93.44M75.56M73.14M
Operating Income100.22M81.33M77.18M43.62M87.97M102.07M113.87M133.74M102.73M106.64M137.49M112.36M
Interest Expense4.92M4.86M5.08M4.95M4.92M4.80M5.04M4.90M4.86M4.86M5.04M5.05M
Other Income (Expense)7.86M5.71M7.75M2.56M6.89M14.13M9.45M9.95M9.04M8.79M5.96M52.65M
Pretax Income93.83M156.41M70.36M42.38M104.52M96.53M-783.00K176.12M84.37M171.27M138.40M159.96M
Income Tax18.80M37.99M16.28M14.61M25.76M23.58M11.01M45.02M22.30M40.20M35.02M28.00M
Net Income75.03M118.42M54.09M27.77M78.75M72.94M-11.79M131.09M62.07M131.07M103.38M131.96M
Net Income growth (YoY)-4.73%+62.34%—-78.82%+26.87%-44.34%-111.40%-0.65%-34.06%——+115.50%
EPS (Basic)1.151.830.840.411.151.06-0.171.890.891.911.521.93
EPS (Diluted)1.111.800.860.411.121.02-0.181.790.881.871.481.88
Shares Outstanding (Basic)65.16M64.74M—67.23M68.52M68.67M—69.46M69.36M68.76M—68.44M
Shares Outstanding (Diluted)67.52M65.77M—67.66M70.31M71.46M—73.06M70.60M70.09M—70.05M
EBITDA122.80M104.01M100.02M64.02M101.20M115.69M131.16M150.82M117.55M122.08M152.50M127.01M
Gross Margin62.30%61.20%59.21%57.91%63.75%63.77%63.55%63.93%64.90%65.37%64.93%62.50%
Operating Margin25.82%21.55%18.97%11.36%23.27%27.38%29.12%35.31%26.07%28.82%38.84%35.12%
Net Margin19.33%31.38%13.30%7.23%20.83%19.57%-3.01%34.61%15.75%35.43%29.20%41.24%

This table shows 12 quarterly periods of Lantheus's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow LNTH's reporting calendar. What is a income statement?

More financial data